BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2981351)

  • 41. NC37-R1 Epstein-Barr virus (EBV): a possible recombinant between intracellular NC37 viral DNA and superinfecting P3HR-1 EBV.
    Fresen KO; Cho MS; Gissmann L; zur Hausen H
    Intervirology; 1980; 12(6):303-10. PubMed ID: 6244234
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Potent inhibition of Epstein-Barr virus by phosphorothioate oligodeoxynucleotides without sequence specification.
    Yao GQ; Grill S; Egan W; Cheng YC
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1420-5. PubMed ID: 8395789
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epstein-Barr virus RNA. V. Viral RNA in a restringently infected, growth-transformed cell line.
    King W; Thomas-Powell AL; Raab-Traub N; Hawke M; Kieff E
    J Virol; 1980 Nov; 36(2):506-18. PubMed ID: 6253674
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interaction of measles and Epstein-Barr viruses in transformed human lymphocytes.
    Jankowski M; Sadowski W
    Acta Microbiol Pol; 1982; 31(1):15-21. PubMed ID: 6184957
    [No Abstract]   [Full Text] [Related]  

  • 45. Epstein-Barr virus immortalizing genes.
    Farrell PJ
    Trends Microbiol; 1995 Mar; 3(3):105-9. PubMed ID: 7773587
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Suppression of EBV release from irradiated B lymphoblastoid cell-lines: superior activity of ganciclovir compared with acyclovir.
    Keever-Taylor CA; Behn B; Konings S; Orentas R; Davies B; Margolis D
    Cytotherapy; 2003; 5(4):323-35. PubMed ID: 12944239
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chromosomal localization of the Epstein-Barr virus (EBV) genome in Bloom's syndrome B-lymphoblastoid cell lines transformed with EBV.
    Shiraishi Y; Taguchi T; Ohta Y; Hirai K
    Chromosoma; 1985; 93(2):157-64. PubMed ID: 3002731
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Infection of leukaemic B lymphocytes by Epstein Barr virus.
    Doyle MG; Catovsky D; Crawford DH
    Leukemia; 1993 Nov; 7(11):1858-64. PubMed ID: 8231253
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of nucleoside analogs on Epstein-Barr virus-induced transformation of human umbilical cord leukocytes and Epstein-Barr virus expression in transformed cells.
    Henderson EE; Long WK; Ribecky R
    Antimicrob Agents Chemother; 1979 Jan; 15(1):101-10. PubMed ID: 218497
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes.
    Woisetschlaeger M; Yandava CN; Furmanski LA; Strominger JL; Speck SH
    Proc Natl Acad Sci U S A; 1990 Mar; 87(5):1725-9. PubMed ID: 2155423
    [TBL] [Abstract][Full Text] [Related]  

  • 51. EBV-activation of human B-lymphocytes.
    Aman P; Lewin N; Nordström M; Klein G
    Curr Top Microbiol Immunol; 1986; 132():266-71. PubMed ID: 3024919
    [No Abstract]   [Full Text] [Related]  

  • 52. The B cell-immortalizing functions of Epstein-Barr virus.
    Ring CJ
    J Gen Virol; 1994 Jan; 75 ( Pt 1)():1-13. PubMed ID: 8113717
    [No Abstract]   [Full Text] [Related]  

  • 53. Prolonged inhibitory effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine against replication of Epstein-Barr virus.
    Lin JC; Smith MC; Pagano JS
    J Virol; 1984 Apr; 50(1):50-5. PubMed ID: 6321799
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of Epstein-Barr virus nuclear antigen(s) in different cell lines by radioimmunoelectrophoresis.
    Sculley TB; Spelsberg TC; Pearson GR
    Intervirology; 1984; 22(4):191-200. PubMed ID: 6096291
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phosphonoacetic acid: inhibition of transformation of human cord blood lymphocytes by Epstein-Barr virus.
    Manor D; Margalith M
    Cancer Biochem Biophys; 1979; 3(4):157-62. PubMed ID: 233303
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Deletion of DNA encoding the first five transmembrane domains of Epstein-Barr virus latent membrane proteins 2A and 2B.
    Longnecker R; Miller CL; Tomkinson B; Miao XQ; Kieff E
    J Virol; 1993 Aug; 67(8):5068-74. PubMed ID: 8392630
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transformation of lymphocytes by Epstein-Barr virus requires only one-fourth of the viral genome.
    Mark W; Sugden B
    Virology; 1982 Oct; 122(2):431-43. PubMed ID: 6293180
    [No Abstract]   [Full Text] [Related]  

  • 58. Unexpected patterns of Epstein-Barr virus gene expression during early stages of B cell transformation.
    Cheung RK; Miyazaki I; Dosch HM
    Int Immunol; 1993 Jul; 5(7):707-16. PubMed ID: 8396414
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human B lymphocytes immortalization by Epstein-Barr virus in the presence of cyclosporin A.
    Pelloquin F; Lamelin JP; Lenoir GM
    In Vitro Cell Dev Biol; 1986 Dec; 22(12):689-94. PubMed ID: 3023278
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The prototypical Epstein-Barr virus-transformed lymphoblastoid cell line IB4 is an unusual variant containing integrated but no episomal viral DNA.
    Hurley EA; Klaman LD; Agger S; Lawrence JB; Thorley-Lawson DA
    J Virol; 1991 Jul; 65(7):3958-63. PubMed ID: 1645805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.